During the past decade, Cardiovascular Research Institute of Dallas conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Research Institute of Dallas" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "ARYx Therapeutics" with 1 trials sponsored, "Abbott" with 1 trials sponsored and "Abbott Medical Devices" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Research Institute of Dallas" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Cardiokine Biopharma, LLC" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Research Institute of Dallas" are "Cardiovascular Disease" (3 trials), "Peripheral Vascular Disease" (3 trials), "Cardiovascular Diseases" (2 trials), "Heart Failure" (2 trials) and "Heart Failure, Congestive" (2 trials). Many other conditions were trialed in "Cardiovascular Research Institute of Dallas" in a lesser frequency.

Most popular intervention types in "Cardiovascular Research Institute of Dallas" are "Drug" (13 trials) and "Device" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "bococizumab (PF-04950615)" (2 trials), "ATI-5923" (1 trials), "Apixaban" (1 trials) and "BAROSTIM NEO® System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Research Institute of Dallas" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Research Institute of Dallas". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cardiovascular Research Institute of Dallas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Research Institute of Dallas, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".